S
Sutro Biopharma, Inc. (STRO)
NGM – Real vaqt narxi. Valyuta: USD
30.52
+0.97 (3.28%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
30.07
-0.45 (-1.47%)
Bozordan keyin: Jun 26, 2026, 6:06 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
30.52
+0.97 (3.28%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
30.07
-0.45 (-1.47%)
Bozordan keyin: Jun 26, 2026, 6:06 PM EDT
This stock has a consensus price target of $26.88 based on the ratings of 20 analysts. The high is $60.00 and the low is $0.80.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 0.8 | $ 26.88 | $ 60 |
| O’zgarish | -97.29% | -9.04% | 103.05% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-06-11 | 63.83% | Truist Securities | $50 | Assumes | Buy |
| 2026-05-28 | 83.49% | Barclays | $56 | Initiates Coverage On | Overweight |
| 2026-05-15 | 40.89% | Leerink Partners | $38 → $43 | Maintains | Outperform |
| 2026-05-15 | 96.59% | Wedbush | $22 → $60 | Upgrades | Neutral → Outperform |
| 2026-05-15 | 63.83% | HC Wainwright & Co. | $28 → $50 | Maintains | Buy |